Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACIFICO trial in older patients with follicular lymphoma
ISRCTN99217456Phase 3Completed
- Sponsor
- University of Liverpool
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
01
Overview
Phase 3, randomised, open-label trial of rituximab, cyclophosphamide, vincristine, prednisolone and fludarabine in follicular lymphoma (FL) (2 arms), sponsored by University of Liverpool. Primary endpoints: Progression-free survival and Grade 3-4 infection toxicity. Started May 2009; status: completed.
02
Drugs
rituximabcyclophosphamidevincristineprednisolonefludarabine
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on ISRCTN99217456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN99217456.